IDNA · iShares Genomics Immunology and Healthcare ETF
United States · RS rating 97 · As of 2026-10-14
| Price | 41.28 USD |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 91 / 92 / 93 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 44 / 57 / 43 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +3.4% |
| Market cap (USD) | – |